Summary

The global mRNA Vaccines & Therapeutics market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.


Further key aspects of the report indicate that:
Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
Chapter 2: Global Production & Consumption Market by Type and End-Use
Chapter 3: Europe Production & Consumption Market by Type and End-Use
Chapter 4: America Production & Consumption Market by Type and End-Use
Chapter 5: Asia Production & Consumption Market by Type and End-Use
Chapter 6: Oceania Production & Consumption Market by Type and End-Use
Chapter 7: Africa Production & Consumption Market by Type and End-Use
Chapter 8: Global Market Forecast by Type, End-Use and Region
Chapter 9: Company information, Sales, Cost, Margin, news etc.
Chapter 10: Market Competition by Companies and Market Concentration Ratio
Chapter 11: Market Impact by Coronavirus.
Chapter 12: Industry Summary
.
Market Segment as follows:

Key Companies
Argos Therapeutics
AstraZeneca
Bayer
BioNTech
Boehringer Ingelheim
CRISPR Therapeutics
CureVac
eTheRNA immunotherapies
Ethris
GlaxoSmithKline Vaccines
In-Cell-Art
Intellia Therapeutics
Janssen
Kernal Biologics
MaxCyte
Moderna Therapeutics
Novartis
PhaseRx
Precision NanoSystems
RaNa Therapeutics

Key Types
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

Key End-Use
Hospital
Clinic
Others

This report can be dispatched within 24-48 Hours.

Table of Contents CHAPTER 1 MARKET OVERVIEW 1.1 Market Definition and Segment 1.1.1 Product Definition 1.1.2 Product Type 1.1.3 End-Use 1.1.4 Marketing Channel 1.2 Major Regions 1.2.1 Europe Market Size and Growth Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD) Figure Europe mRNA Vaccines & Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD) 1.2.2 America Market Size and Growth Figure America mRNA Vaccines & Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD) Figure America mRNA Vaccines & Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD) 1.2.3 Asia Market Size and Growth Figure Asia mRNA Vaccines & Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD) Figure AsiamRNA Vaccines & Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD) 1.2.4 Oceania Market Size and Growth Figure Oceania mRNA Vaccines & Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD) Figure Oceania mRNA Vaccines & Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD) 1.2.5 Africa Market Size and Growth Figure Africa mRNA Vaccines & Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD) Figure Africa mRNA Vaccines & Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD) CHAPTER 2 GLOBAL MARKET SEGMENTATION 2.1 Global Production Overview Table Global mRNA Vaccines & Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020 2.2 Global Consumption Overview Table Global mRNA Vaccines & Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020 2.3 Global Production by Type Table Global mRNA Vaccines & Therapeutics Revenue by Type, 2015-2020 (Million USD) Figure Global mRNA Vaccines & Therapeutics Revenue Share by Type in 2020 (Million USD) Table Global mRNA Vaccines & Therapeutics Production Volume by Type, 2015-2020 (Volume) Figure Global mRNA Vaccines & Therapeutics Production Volume Share by Type in 2020 (Volume) 2.4 Global Consumption by End-Use Table Global mRNA Vaccines & Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD) Figure Global mRNA Vaccines & Therapeutics Consumption Value Share by End-Use in 2020 (Million USD) Table Global mRNA Vaccines & Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume) Figure Global mRNA Vaccines & Therapeutics Consumption Volume Share by End-Use in 2020 (Volume) 2.5 Global Consumption by Region Table Global mRNA Vaccines & Therapeutics Consumption Value by Region, 2015-2020 (Million USD) Table Global mRNA Vaccines & Therapeutics Consumption Volume by Region, 2015-2020 (Volume) CHAPTER 3 Europe MARKET SEGMENTATION 3.1 Europe Production Overview Table Europe mRNA Vaccines & Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020 3.2 Europe Consumption Overview Table Europe mRNA Vaccines & Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020 3.3 Europe Production by Type Table Europe mRNA Vaccines & Therapeutics Revenue by Type, 2015-2020 (Million USD) Figure Europe mRNA Vaccines & Therapeutics Revenue Share by Type in 2020 (Million USD) Table Europe mRNA Vaccines & Therapeutics Production Volume by Type, 2015-2020 (Volume) Figure Europe mRNA Vaccines & Therapeutics Production Volume Share by Type in 2020 (Volume) 3.4 Europe Consumption by End-Use Table Europe mRNA Vaccines & Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD) Figure Europe mRNA Vaccines & Therapeutics Consumption Value Share by End-Use in 2020 (Million USD) Table Europe mRNA Vaccines & Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume) Figure Europe mRNA Vaccines & Therapeutics Consumption Volume Share by End-Use in 2020 (Volume) 3.5 Europe Consumption by Region Table Europe mRNA Vaccines & Therapeutics Consumption Value by Region, 2015-2020 (Million USD) Table Europe mRNA Vaccines & Therapeutics Consumption Volume by Region, 2015-2020 (Volume) CHAPTER 4 AMERICA MARKET SEGMENTATION 4.1 America Production Overview Table America mRNA Vaccines & Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020 4.2 America Consumption Overview Table America mRNA Vaccines & Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020 4.3 America Production by Type Table America mRNA Vaccines & Therapeutics Revenue by Type, 2015-2020 (Million USD) Figure America mRNA Vaccines & Therapeutics Revenue Share by Type in 2020 (Million USD) Table America mRNA Vaccines & Therapeutics Production Volume by Type, 2015-2020 (Volume) Figure America mRNA Vaccines & Therapeutics Production Volume Share by Type in 2020 (Volume) 4.4 America Consumption by End-Use Table America mRNA Vaccines & Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD) Figure America mRNA Vaccines & Therapeutics Consumption Value Share by End-Use in 2020 (Million USD) Table America mRNA Vaccines & Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume) Figure America mRNA Vaccines & Therapeutics Consumption Volume Share by End-Use in 2020 (Volume) 4.5 America Consumption by Region Table America mRNA Vaccines & Therapeutics Consumption Value by Region, 2015-2020 (Million USD) Table America mRNA Vaccines & Therapeutics Consumption Volume by Region, 2015-2020 (Volume) CHAPTER 5 ASIA MARKET SEGMENTATION 5.1 Asia Production Overview Table Asia mRNA Vaccines & Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020 5.2 Asia Consumption Overview Table Asia mRNA Vaccines & Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020 5.3 Asia Production by Type Table Asia mRNA Vaccines & Therapeutics Revenue by Type, 2015-2020 (Million USD) Figure Asia mRNA Vaccines & Therapeutics Revenue Share by Type in 2020 (Million USD) Table Asia mRNA Vaccines & Therapeutics Production Volume by Type, 2015-2020 (Volume) Figure Asia mRNA Vaccines & Therapeutics Production Volume Share by Type in 2020 (Volume) 5.4 Asia Consumption by End-Use Table Asia mRNA Vaccines & Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD) Figure Asia mRNA Vaccines & Therapeutics Consumption Value Share by End-Use in 2020 (Million USD) Table Asia mRNA Vaccines & Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume) Figure Asia mRNA Vaccines & Therapeutics Consumption Volume Share by End-Use in 2020 (Volume) 5.5 Asia Consumption by Region Table Asia mRNA Vaccines & Therapeutics Consumption Value by Region, 2015-2020 (Million USD) Table Asia mRNA Vaccines & Therapeutics Consumption Volume by Region, 2015-2020 (Volume) CHAPTER 6 OCEANIA MARKET SEGMENTATION 6.1 Oceania Production Overview Table Oceania mRNA Vaccines & Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020 6.2 Oceania Consumption Overview Table Oceania mRNA Vaccines & Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020 6.3 Oceania Production by Type Table Oceania mRNA Vaccines & Therapeutics Revenue by Type, 2015-2020 (Million USD) Figure Oceania mRNA Vaccines & Therapeutics Revenue Share by Type in 2020 (Million USD) Table Oceania mRNA Vaccines & Therapeutics Production Volume by Type, 2015-2020 (Volume) Figure Oceania mRNA Vaccines & Therapeutics Production Volume Share by Type in 2020 (Volume) 6.4 Oceania Consumption by End-Use Table Oceania mRNA Vaccines & Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD) Figure Oceania mRNA Vaccines & Therapeutics Consumption Value Share by End-Use in 2020 (Million USD) Table Oceania mRNA Vaccines & Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume) Figure Oceania mRNA Vaccines & Therapeutics Consumption Volume Share by End-Use in 2020 (Volume) 6.5 Oceania Consumption by Region Table Oceania mRNA Vaccines & Therapeutics Consumption Value by Region, 2015-2020 (Million USD) Table Oceania mRNA Vaccines & Therapeutics Consumption Volume by Region, 2015-2020 (Volume) CHAPTER 7 AFRICA MARKET SEGMENTATION 7.1 Africa Production Overview Table Africa mRNA Vaccines & Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020 7.2 Africa Consumption Overview Table Africa mRNA Vaccines & Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020 7.3 Africa Production by Type Table Africa mRNA Vaccines & Therapeutics Revenue by Type, 2015-2020 (Million USD) Figure Africa mRNA Vaccines & Therapeutics Revenue Share by Type in 2020 (Million USD) Table Africa mRNA Vaccines & Therapeutics Production Volume by Type, 2015-2020 (Volume) Figure Africa mRNA Vaccines & Therapeutics Production Volume Share by Type in 2020 (Volume) 7.4 Africa Consumption by End-Use Table Africa mRNA Vaccines & Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD) Figure Africa mRNA Vaccines & Therapeutics Consumption Value Share by End-Use in 2020 (Million USD) Table Africa mRNA Vaccines & Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume) Figure Africa mRNA Vaccines & Therapeutics Consumption Volume Share by End-Use in 2020 (Volume) 7.5 Africa Consumption by Region Table Africa mRNA Vaccines & Therapeutics Consumption Value by Region, 2015-2020 (Million USD) Table Africa mRNA Vaccines & Therapeutics Consumption Volume by Region, 2015-2020 (Volume) CHAPTER 8 GLOBAL MARKET FORECAST 8.1 Global mRNA Vaccines & Therapeutics Production Forecast Figure Global mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast 2020E-2025F (Million USD) Figure Global mRNA Vaccines & Therapeutics Production Volume and Growth Rate Forecast 2020E-2025F (Volume) 8.2 Global mRNA Vaccines & Therapeutics Forecast by Type Table Global mRNA Vaccines & Therapeutics Revenue by Type, 2020E-2025F (Million USD) Figure Global mRNA Vaccines & Therapeutics Revenue Share by Type in 2025 (Million USD) Table Global mRNA Vaccines & Therapeutics Production Volume by Type, 2020E-2025F (Volume) Figure Global mRNA Vaccines & Therapeutics Production Volume Share by Type in 2025 (Volume) 8.3 Global mRNA Vaccines & Therapeutics Forecast by End-Use (2020E-2025F) Table Global mRNA Vaccines & Therapeutics Consumption Value by End-Use, 2020E-2025F (Million USD) Figure Global mRNA Vaccines & Therapeutics Consumption Value Share by End-Use in 2025 (Million USD) Table Global mRNA Vaccines & Therapeutics Consumption Volume by End-Use, 2020E-2025F (Volume) 8.4 Global mRNA Vaccines & Therapeutics Forecast by Region (2020E-2025F) Table Global mRNA Vaccines & Therapeutics Consumption Value by Region, 2020E-2025F (Million USD) Figure Global mRNA Vaccines & Therapeutics Consumption Value Share by Region in 2025 (Million USD) Table Global mRNA Vaccines & Therapeutics Consumption Volume by Region, 2020E-2025F (Volume) Figure Global mRNA Vaccines & Therapeutics Consumption Volume Share by Region in 2025 (Volume) CHAPTER 9 GLOBAL MAJOR COMPANIES LIST 9.1 Argos Therapeutics 9.1.1 Argos Therapeutics Profile Table Argos Therapeutics Overview List 9.1.2 Argos Therapeutics Products & Services 9.1.3 Argos Therapeutics Company Dynamics & News 9.1.4 Argos Therapeutics Business Operation Conditions Table Business Operation of Argos Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 9.2 AstraZeneca 9.2.1 AstraZeneca Profile Table AstraZeneca Overview List 9.2.2 AstraZeneca Products & Services 9.2.3 AstraZeneca Company Dynamics & News 9.2.4 AstraZeneca Business Operation Conditions Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 9.3 Bayer 9.3.1 Bayer Profile Table Bayer Overview List 9.3.2 Bayer Products & Services 9.3.3 Bayer Company Dynamics & News 9.3.4 Bayer Business Operation Conditions Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 9.4 BioNTech 9.4.1 BioNTech Profile Table BioNTech Overview List 9.4.2 BioNTech Products & Services 9.4.3 BioNTech Company Dynamics & News 9.4.4 BioNTech Business Operation Conditions Table Business Operation of BioNTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 9.5 Boehringer Ingelheim 9.5.1 Boehringer Ingelheim Profile Table Boehringer Ingelheim Overview List 9.5.2 Boehringer Ingelheim Products & Services 9.5.3 Boehringer Ingelheim Company Dynamics & News 9.5.4 Boehringer Ingelheim Business Operation Conditions Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 9.6 CRISPR Therapeutics 9.6.1 CRISPR Therapeutics Profile Table CRISPR Therapeutics Overview List 9.6.2 CRISPR Therapeutics Products & Services 9.6.3 CRISPR Therapeutics Company Dynamics & News 9.6.4 CRISPR Therapeutics Business Operation Conditions Table Business Operation of CRISPR Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 9.7 CureVac 9.7.1 CureVac Profile Table CureVac Overview List 9.7.2 CureVac Products & Services 9.7.3 CureVac Company Dynamics & News 9.7.4 CureVac Business Operation Conditions Table Business Operation of CureVac (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 9.8 eTheRNA immunotherapies 9.8.1 eTheRNA immunotherapies Profile Table eTheRNA immunotherapies Overview List 9.8.2 eTheRNA immunotherapies Products & Services 9.8.3 eTheRNA immunotherapies Company Dynamics & News 9.8.4 eTheRNA immunotherapies Business Operation Conditions Table Business Operation of eTheRNA immunotherapies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 9.9 Ethris 9.9.1 Ethris Profile Table Ethris Overview List 9.9.2 Ethris Products & Services 9.9.3 Ethris Company Dynamics & News 9.9.4 Ethris Business Operation Conditions Table Business Operation of Ethris (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 9.10 GlaxoSmithKline Vaccines 9.10.1 GlaxoSmithKline Vaccines Profile Table GlaxoSmithKline Vaccines Overview List 9.10.2 GlaxoSmithKline Vaccines Products & Services 9.10.3 GlaxoSmithKline Vaccines Company Dynamics & News 9.10.4 GlaxoSmithKline Vaccines Business Operation Conditions Table Business Operation of GlaxoSmithKline Vaccines (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 9.11 In-Cell-Art 9.11.1 In-Cell-Art Profile Table In-Cell-Art Overview List 9.11.2 In-Cell-Art Products & Services 9.11.3 In-Cell-Art Company Dynamics & News 9.11.4 In-Cell-Art Business Operation Conditions Table Business Operation of In-Cell-Art (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 9.12 Intellia Therapeutics 9.12.1 Intellia Therapeutics Profile Table Intellia Therapeutics Overview List 9.12.2 Intellia Therapeutics Products & Services 9.12.3 Intellia Therapeutics Company Dynamics & News 9.12.4 Intellia Therapeutics Business Operation Conditions Table Business Operation of Intellia Therapeutics (Sales Revenue, Cost, Gross Margin) 9.13 Janssen 9.13.1 Janssen Profile Table Janssen Overview List 9.13.2 Janssen Products & Services 9.13.3 Janssen Company Dynamics & News 9.13.4 Janssen Business Operation Conditions Table Business Operation of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) 9.14 Kernal Biologics 9.14.1 Kernal Biologics Profile Table Kernal Biologics Overview List 9.14.2 Kernal Biologics Products & Services 9.14.3 Kernal Biologics Company Dynamics & News 9.14.4 Kernal Biologics Business Operation Conditions Table Business Operation of Kernal Biologics (Sales Revenue, Cost, Gross Margin) 9.15 MaxCyte 9.15.1 MaxCyte Profile Table MaxCyte Overview List 9.15.2 MaxCyte Products & Services 9.15.3 MaxCyte Company Dynamics & News 9.15.4 MaxCyte Business Operation Conditions Table Business Operation of MaxCyte (Sales Revenue, Cost, Gross Margin) 9.16 Moderna Therapeutics 9.16.1 Moderna Therapeutics Profile Table Moderna Therapeutics Overview List 9.16.2 Moderna Therapeutics Products & Services 9.16.3 Moderna Therapeutics Company Dynamics & News 9.16.4 Moderna Therapeutics Business Operation Conditions Table Business Operation of Moderna Therapeutics (Sales Revenue, Cost, Gross Margin) 9.17 Novartis 9.17.1 Novartis Profile Table Novartis Overview List 9.17.2 Novartis Products & Services 9.17.3 Novartis Company Dynamics & News 9.17.4 Novartis Business Operation Conditions Table Business Operation of Novartis (Sales Revenue, Cost, Gross Margin) 9.18 PhaseRx 9.18.1 PhaseRx Profile Table PhaseRx Overview List 9.18.2 PhaseRx Products & Services 9.18.3 PhaseRx Company Dynamics & News 9.18.4 PhaseRx Business Operation Conditions Table Business Operation of PhaseRx (Sales Revenue, Cost, Gross Margin) 9.19 Precision NanoSystems 9.19.1 Precision NanoSystems Profile Table Precision NanoSystems Overview List 9.19.2 Precision NanoSystems Products & Services 9.19.3 Precision NanoSystems Company Dynamics & News 9.19.4 Precision NanoSystems Business Operation Conditions Table Business Operation of Precision NanoSystems (Sales Revenue, Cost, Gross Margin) 9.20 RaNa Therapeutics 9.20.1 RaNa Therapeutics Profile Table RaNa Therapeutics Overview List 9.20.2 RaNa Therapeutics Products & Services 9.20.3 RaNa Therapeutics Company Dynamics & News 9.20.4 RaNa Therapeutics Business Operation Conditions Table Business Operation of RaNa Therapeutics (Sales Revenue, Cost, Gross Margin) PART 10 MARKET COMPETITION 10.1 Key Company Market Share Table Global mRNA Vaccines & Therapeutics Sales Revenue 2015-2020E, by Companies, in USD Million Table Global mRNA Vaccines & Therapeutics Sales Revenue Share, 2015-2020E, by Companies, in USD Table Global mRNA Vaccines & Therapeutics Sales Volume by Companies, 2015-2020E (Volume) Table Global mRNA Vaccines & Therapeutics Sales Volume Share by Companies, 2015-2020E (Volume) 10.2 Regional Market Concentration Figure Europe mRNA Vaccines & Therapeutics Market Concentration Ratio in 2020E Figure America mRNA Vaccines & Therapeutics Market Concentration Ratio in 2020E Figure Asia mRNA Vaccines & Therapeutics Market Concentration Ratio in 2020E Figure Oceania mRNA Vaccines & Therapeutics Market Concentration Ratio in 2020E Figure Africa mRNA Vaccines & Therapeutics Market Concentration Ratio in 2020E PART 11 CORONAVIRUS IMPACT ON mRNA Vaccines & Therapeutics INDUSTRY 11.1 Impact on Industry Upstream 11.2 Impact on Industry Downstream 11.3 Impact on Industry Channels 11.4 Impact on Industry Competition 11.5 Impact on Industry Obtain Employment PART 12 mRNA Vaccines & Therapeutics INDUSTRY SUMMARY & CONCLUSION List of Table Table Global mRNA Vaccines & Therapeutics Revenue by Type, 2015-2020 (Million USD) Table Global mRNA Vaccines & Therapeutics Production Volume by Type, 2015-2020 (Volume) Table Global mRNA Vaccines & Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD) Table Global mRNA Vaccines & Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume) Table Global mRNA Vaccines & Therapeutics Consumption Value by Region, 2015-2020 (Million USD) Table Global mRNA Vaccines & Therapeutics Consumption Volume by Region, 2015-2020 (Volume) Table Europe mRNA Vaccines & Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020 Table Europe mRNA Vaccines & Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020 Table Europe mRNA Vaccines & Therapeutics Revenue by Type, 2015-2020 (Million USD) Table Europe mRNA Vaccines & Therapeutics Production Volume by Type, 2015-2020 (Volume) Table Europe mRNA Vaccines & Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD) Table Europe mRNA Vaccines & Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume) Table Europe mRNA Vaccines & Therapeutics Consumption Value by Region, 2015-2020 (Million USD) Table Europe mRNA Vaccines & Therapeutics Consumption Volume by Region, 2015-2020 (Volume) Table America mRNA Vaccines & Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020 Table America mRNA Vaccines & Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020 Table America mRNA Vaccines & Therapeutics Revenue by Type, 2015-2020 (Million USD) Table America mRNA Vaccines & Therapeutics Production Volume by Type, 2015-2020 (Volume) Table America mRNA Vaccines & Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD) Table America mRNA Vaccines & Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume) Table America mRNA Vaccines & Therapeutics Consumption Value by Region, 2015-2020 (Million USD) Table America mRNA Vaccines & Therapeutics Consumption Volume by Region, 2015-2020 (Volume) Table Asia mRNA Vaccines & Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020 Table Asia mRNA Vaccines & Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020 Table Asia mRNA Vaccines & Therapeutics Revenue by Type, 2015-2020 (Million USD) Table Asia mRNA Vaccines & Therapeutics Production Volume by Type, 2015-2020 (Volume) Table Asia mRNA Vaccines & Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD) Table Asia mRNA Vaccines & Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume) Table Asia mRNA Vaccines & Therapeutics Consumption Value by Region, 2015-2020 (Million USD) Table Asia mRNA Vaccines & Therapeutics Consumption Volume by Region, 2015-2020 (Volume) Table Oceania mRNA Vaccines & Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020 Table Oceania mRNA Vaccines & Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020 Table Oceania mRNA Vaccines & Therapeutics Revenue by Type, 2015-2020 (Million USD) Table Oceania mRNA Vaccines & Therapeutics Production Volume by Type, 2015-2020 (Volume) Table Oceania mRNA Vaccines & Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD) Table Oceania mRNA Vaccines & Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume) Table Oceania mRNA Vaccines & Therapeutics Consumption Value by Region, 2015-2020 (Million USD) Table Oceania mRNA Vaccines & Therapeutics Consumption Volume by Region, 2015-2020 (Volume) Table Africa mRNA Vaccines & Therapeutics Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020 Table Africa mRNA Vaccines & Therapeutics Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020 Table Africa mRNA Vaccines & Therapeutics Revenue by Type, 2015-2020 (Million USD) Table Africa mRNA Vaccines & Therapeutics Production Volume by Type, 2015-2020 (Volume) Table Africa mRNA Vaccines & Therapeutics Consumption Value by End-Use, 2015-2020 (Million USD) Table Africa mRNA Vaccines & Therapeutics Consumption Volume by End-Use, 2015-2020 (Volume) Table Africa mRNA Vaccines & Therapeutics Consumption Value by Region, 2015-2020 (Million USD) Table Africa mRNA Vaccines & Therapeutics Consumption Volume by Region, 2015-2020 (Volume) Table Global mRNA Vaccines & Therapeutics Revenue by Type, 2020E-2025F (Million USD) Table Global mRNA Vaccines & Therapeutics Production Volume by Type, 2020E-2025F (Volume) Table Global mRNA Vaccines & Therapeutics Consumption Value by End-Use, 2020E-2025F (Million USD) Table Global mRNA Vaccines & Therapeutics Consumption Volume by End-Use, 2020E-2025F (Volume) Table Global mRNA Vaccines & Therapeutics Consumption Value by Region, 2020E-2025F (Million USD) Table Global mRNA Vaccines & Therapeutics Consumption Volume by Region, 2020E-2025F (Volume) Table Argos Therapeutics Overview List Table Business Operation of Argos Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table AstraZeneca Overview List Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Bayer Overview List Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table BioNTech Overview List Table Business Operation of BioNTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Boehringer Ingelheim Overview List Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table CRISPR Therapeutics Overview List Table Business Operation of CRISPR Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table CureVac Overview List Table Business Operation of CureVac (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table eTheRNA immunotherapies Overview List Table Business Operation of eTheRNA immunotherapies (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Ethris Overview List Table Business Operation of Ethris (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table GlaxoSmithKline Vaccines Overview List Table Business Operation of GlaxoSmithKline Vaccines (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table In-Cell-Art Overview List Table Business Operation of In-Cell-Art (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Intellia Therapeutics Overview List Table Business Operation of Intellia Therapeutics (Sales Revenue, Cost, Gross Margin) Table Janssen Overview List Table Business Operation of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Kernal Biologics Overview List Table Business Operation of Kernal Biologics (Sales Revenue, Cost, Gross Margin) Table MaxCyte Overview List Table Business Operation of MaxCyte (Sales Revenue, Cost, Gross Margin) Table Moderna Therapeutics Overview List Table Business Operation of Moderna Therapeutics (Sales Revenue, Cost, Gross Margin) Table Novartis Overview List Table Business Operation of Novartis (Sales Revenue, Cost, Gross Margin) Table PhaseRx Overview List Table Business Operation of PhaseRx (Sales Revenue, Cost, Gross Margin) Table Precision NanoSystems Overview List Table Business Operation of Precision NanoSystems (Sales Revenue, Cost, Gross Margin) Table RaNa Therapeutics Overview List Table Business Operation of RaNa Therapeutics (Sales Revenue, Cost, Gross Margin) Table Global mRNA Vaccines & Therapeutics Sales Revenue 2015-2020E, by Companies, in USD Million Table Global mRNA Vaccines & Therapeutics Sales Revenue Share, 2015-2020E, by Companies, in USD Table Global mRNA Vaccines & Therapeutics Sales Volume by Companies, 2015-2020E (Volume) Table Global mRNA Vaccines & Therapeutics Sales Volume Share by Companies, 2015-2020E (Volume) List of Figure Figure Europe mRNA Vaccines & Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD) Figure Europe mRNA Vaccines & Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD) Figure America mRNA Vaccines & Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD) Figure America mRNA Vaccines & Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD) Figure Asia mRNA Vaccines & Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD) Figure AsiamRNA Vaccines & Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD) Figure Oceania mRNA Vaccines & Therapeutics Market Size and Growth Rate, 2015E-2020F (Million USD) Figure Oceania mRNA Vaccines & Therapeutics Market Forecast and Growth Rate, 2020E-2025F (Million USD) Figure Africa mRNA Vaccines & Ther

Vaccines Isothermal Boxes Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Vaccines Isothermal Boxes Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...

Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Advanced Therapeutics Pharmaceutical Outsourcing Market: The report discusses everything a marketer requires before investing in the global Advanced Therapeutics Pharmaceutical Outsourcing Mar...

Global Antibody Based Therapeutics Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Antibody Based Therapeutics Market: The report discusses everything a marketer requires before investing in the global Antibody Based Therapeutics Market during the forecast period 2023-2030. ...

Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...

Europe Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...

North America Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...

Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity...

Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...

Global Office-Based Sleep Therapeutics Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Office-Based Sleep Therapeutics Market: The report discusses everything a marketer requires before investing in the global Office-Based Sleep Therapeutics Market during the forecast period 202...

Global Digital Therapeutics Navigation Platform Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Digital Therapeutics Navigation Platform Market: The report discusses everything a marketer requires before investing in the global Digital Therapeutics Navigation Platform Market during the f...

Global Substance Abuse Disorder Therapeutics Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Substance Abuse Disorder Therapeutics Market: The report discusses everything a marketer requires before investing in the global Substance Abuse Disorder Therapeutics Market during the forecas...